We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+0.88%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$191M
AUM Growth
-$20.5M
Cap. Flow
-$12.4M
Cap. Flow %
-6.5%
Top 10 Hldgs %
8%
Holding
450
New
8
Increased
100
Reduced
215
Closed
125

Top Buys

Rank Stock Value
1
BIPC icon
Brookfield Infrastructure
BIPC
+$1.03M
2
OXLC
Oxford Lane Capital
OXLC
+$1,000K
3
ECC
Eagle Point Credit Company
ECC
+$951K
4
ORAN
Orange
ORAN
+$441K
5
SNP
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
+$424K

Top Sells

Rank Stock Value
1
DKL icon
Delek Logistics
DKL
+$2.13M
2
WES icon
Western Midstream Partners
WES
+$888K
3
CNXM
CNX Midstream Partners LP
CNXM
+$744K
4
OSB
Norbord Inc.
OSB
+$695K
5
MPC icon
Marathon Petroleum
MPC
+$594K

Sector Composition

Rank Sector Weight
1 Healthcare 32.34%
2 Real Estate 18.02%
3 Energy 12.43%
4 Materials 10.7%
5 Financials 6.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVAX icon
101
Novavax
NVAX
$1.21B
$733K 0.38%
6,766
-926
-12% -$113K
PSXP
102
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
$732K 0.38%
31,770
+3,956
+14% +$109K
RARE icon
103
Ultragenyx Pharmaceutical
RARE
$2.56B
$706K 0.37%
8,587
+723
+9% +$59.9K
TVTX icon
104
Travere Therapeutics
TVTX
$5.2B
$704K 0.37%
38,150
+3,213
+9% +$62.4K
CVI icon
105
CVR Energy
CVI
$3.39B
$695K 0.36%
56,147
+6,604
+13% +$112K
INSM icon
106
Insmed
INSM
$22.6B
$691K 0.36%
21,496
+1,811
+9% +$52.1K
MFIC icon
107
MidCap Financial Investment
MFIC
$811M
$690K 0.36%
83,492
-10,355
-11% -$95.8K
XLRN
108
DELISTED
Acceleron Pharma
XLRN
$690K 0.36%
6,129
+516
+9% +$51.4K
AMGN icon
109
Amgen
AMGN
$212B
$682K 0.36%
2,683
+227
+9% +$56.2K
ALNY icon
110
Alnylam Pharmaceuticals
ALNY
$38.5B
$679K 0.36%
4,662
+393
+9% +$55.8K
HALO icon
111
Halozyme
HALO
$9.9B
$673K 0.35%
25,612
+2,157
+9% +$60.1K
EXEL icon
112
Exelixis
EXEL
$14.2B
$638K 0.33%
26,104
+2,199
+9% +$51.3K
ALXN
113
DELISTED
Alexion Pharmaceuticals
ALXN
$612K 0.32%
5,347
+181
+4% +$19.5K
BIIB icon
114
Biogen
BIIB
$30.4B
$594K 0.31%
2,093
+121
+6% +$33.7K
VRTX icon
115
Vertex Pharmaceuticals
VRTX
$124B
$592K 0.31%
2,176
-3
-0.1% -$828
KURA icon
116
Kura Oncology
KURA
$826M
$579K 0.3%
18,907
-2,572
-12% -$56.8K
IRWD icon
117
Ironwood Pharmaceuticals
IRWD
$626M
$575K 0.3%
63,946
+5,386
+9% +$53.5K
BBDC icon
118
Barings BDC
BBDC
$885M
$572K 0.3%
71,531
-60,976
-46% -$485K
INCY icon
119
Incyte
INCY
$26B
$570K 0.3%
6,348
+535
+9% +$51.6K
TCPC icon
120
BlackRock TCP Capital
TCPC
$274M
$564K 0.3%
57,530
-14,277
-20% -$138K
REGN icon
121
Regeneron Pharmaceuticals
REGN
$72.9B
$556K 0.29%
994
+13
+1% +$7.88K
PTCT icon
122
PTC Therapeutics
PTCT
$6.25B
$555K 0.29%
11,863
+999
+9% +$49.2K
ENTA icon
123
Enanta Pharmaceuticals
ENTA
$367M
$551K 0.29%
12,046
+1,015
+9% +$49.2K
PSEC icon
124
Prospect Capital
PSEC
$1.12B
$531K 0.28%
105,608
-29,786
-22% -$150K
PFLT icon
125
PennantPark Floating Rate Capital
PFLT
$705M
$530K 0.28%
62,760
-13,385
-18% -$113K
3 4
5
6 7

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q3 2020 Portfolio in Review

As of Q3 2020, Virtus ETF Advisers held 450 positions worth $191M, down 9.7% from $211M the previous quarter. Its ten largest holdings account for 8% of the portfolio.

Virtus ETF Advisers withdrew a net $12.4M in Q3 2020, closing 125 positions and reducing 215 holdings. Its most notable exit was CNX Midstream Partners LP, an estimated $744K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 34% a quarter earlier, followed by Real Estate and Energy.

Against the trend, Virtus ETF Advisers opened a new position in Oxford Lane Capital worth $1.03M.

  • Virtus ETF Advisers's largest Q3 2020 buy was Oxford Lane Capital: 46,671 shares worth $1.03M.
  • Virtus ETF Advisers added most to Brookfield Infrastructure in Q3 2020, an estimated $1.03M increase.
  • Virtus ETF Advisers's biggest Q3 2020 reduction was Delek Logistics, cutting an estimated $2.13M.
  • Virtus ETF Advisers fully exited CNX Midstream Partners LP in Q3 2020, selling an estimated $744K.
  • Virtus ETF Advisers's ten largest holdings make up 8% of its $191M portfolio in Q3 2020.
  • Virtus ETF Advisers opened 8 new positions and closed 125 in Q3 2020.
  • Virtus ETF Advisers's portfolio value fell 9.7% quarter-over-quarter to $191M.

Based on Virtus ETF Advisers's 13F filing for Q3 2020, filed 13 Nov 2020.